Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina M Ronen

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Scientific Reports|July 21, 2019
PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survivalGeorgios Batsios, Pavithra Viswanath, Elavarasan Subramani, et al.
Neuro-Oncology|January 29, 2022
Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomasCéline Taglang, Georgios Batsios, Joydeep Mukherjee, et al.
Theranostics|August 6, 2020
MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade gliomaAbigail R Molloy, Chloé Najac, Pavithra Viswanath, et al.
Plos One|September 23, 2014
Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylaseJose L Izquierdo-Garcia, Larry M Cai, Myriam M Chaumeil, et al.
Scientific Reports|March 30, 2023
Hyperpolarized δ-[1- <sup>13</sup>C]gluconolactone imaging visualizes response to TERT or GABPB1 targeting therapy for glioblastomaNoriaki Minami, Donghyun Hong, Celine Taglang, et al.
Molecular Cancer Therapeutics|January 25, 2006
Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cellsMounia Beloueche-Babari, L Elizabeth Jackson, Nada M S Al-Saffar, et al.
Neuro-Oncology|February 17, 2010
Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastomaDimpy Koul, Ruijun Shen, Yong-Wan Kim, et al.
Neuroimage. Clinical|July 21, 2016
Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoringMyriam M Chaumeil, Marina Radoul, Chloé Najac, et al.
Magnetic Resonance in Medicine|May 27, 2016
Accelerated high-bandwidth MR spectroscopic imaging using compressed sensingPeng Cao, Peter J Shin, Ilwoo Park, et al.
Scientific Reports|April 12, 2020
In vivo detection of γ-glutamyl-transferase up-regulation in glioma using hyperpolarized γ-glutamyl-[1-<sup>13</sup>C]glycineGeorgios Batsios, Chloé Najac, Peng Cao, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Scientific Reports|July 21, 2019
PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survivalGeorgios Batsios, Pavithra Viswanath, Elavarasan Subramani, et al.
Neuro-Oncology|January 29, 2022
Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomasCéline Taglang, Georgios Batsios, Joydeep Mukherjee, et al.
Theranostics|August 6, 2020
MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade gliomaAbigail R Molloy, Chloé Najac, Pavithra Viswanath, et al.
Plos One|September 23, 2014
Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylaseJose L Izquierdo-Garcia, Larry M Cai, Myriam M Chaumeil, et al.
Scientific Reports|March 30, 2023
Hyperpolarized δ-[1- <sup>13</sup>C]gluconolactone imaging visualizes response to TERT or GABPB1 targeting therapy for glioblastomaNoriaki Minami, Donghyun Hong, Celine Taglang, et al.
Molecular Cancer Therapeutics|January 25, 2006
Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cellsMounia Beloueche-Babari, L Elizabeth Jackson, Nada M S Al-Saffar, et al.
Neuro-Oncology|February 17, 2010
Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastomaDimpy Koul, Ruijun Shen, Yong-Wan Kim, et al.
Neuroimage. Clinical|July 21, 2016
Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoringMyriam M Chaumeil, Marina Radoul, Chloé Najac, et al.
Magnetic Resonance in Medicine|May 27, 2016
Accelerated high-bandwidth MR spectroscopic imaging using compressed sensingPeng Cao, Peter J Shin, Ilwoo Park, et al.
Scientific Reports|April 12, 2020
In vivo detection of γ-glutamyl-transferase up-regulation in glioma using hyperpolarized γ-glutamyl-[1-<sup>13</sup>C]glycineGeorgios Batsios, Chloé Najac, Peng Cao, et al.
Pageof 8